Literature DB >> 7363021

Intravenous methylprednisolone in minimal change nephrotic syndrome.

C Ponticelli, E Imbasciati, N Case, P Zucchelli, L Cagnoli, S Pasquali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7363021      PMCID： PMC1600822          DOI： 10.1136/bmj.280.6215.685

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Long-term assessment of steroid therapy in childhood nephrosis.

Authors:  G C Arneil; C N Lam
Journal:  Lancet       Date:  1966-10-15       Impact factor: 79.321

2.  Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children.

Authors:  M Abramowicz; H L Barnett; C M Edelmann; I Greifer; O Kobayashi; G C Arneil; B A Barron; G Gordillo-P; N Hallman; H A Tiddens
Journal:  Lancet       Date:  1970-05-09       Impact factor: 79.321

3.  Association of postmedication hypocortisolism with early first relapse of idiopathic nephrotic syndrome.

Authors:  S Leisti; N Hallman; O Koskimies; J Perheentupa; J Rapola; J Vilska
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321
  3 in total
  3 in total

Review 1.  Immunosuppressive therapy in the nephrotic syndrome in children.

Authors:  R S Trompeter
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

2.  Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus.

Authors:  D A Isenberg; W J Morrow; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

3.  Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.

Authors:  E Imbasciati; R Gusmano; A Edefonti; P Zucchelli; C Pozzi; C Grassi; M Della Volpe; F Perfumo; P Petrone; M Picca
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.